連續血糖監測(Continuous Glucose Monitoring, CGM) 是一種可以即時反應血糖數據的監測方法，隨著科技的進步，現今的連續式血糖監測產品已可與智慧型設備連結，將數據做更廣泛的應用。

本研究主要以連續式血糖監測技術作為研究主軸，先透過專利檢索分析，產生連續式血糖監測技術領域的專利地圖，並進一步對重要專利權人進行探討，分別以統計高被引專利與個案技術發展路徑分析的方式，歸納出連續式血糖監測領域之關鍵技術。

本研究希望以專利的角度分析目前技術發展現況，從總體申請概況到個案的發展分析，彙整出關鍵專利技術與重要廠商的技術發展路徑，提供給將來欲進行連續式血糖量測產品開發的企業，幫助企業能擬訂更高效的研發策略與專利申請方向，並找出相關產品延伸與應用的可能性。

Continuous Glucose Monitoring (CGM) is a monitoring method that can reflect blood Glucose data in real-time. With the advancement of technology, Continuous Glucose Monitoring products can connect with smart devices for a broader range of applications.

This study focuses on continuous glucose monitoring technology, first through the analysis of patent search, producing a patent map of continuous glucose monitoring technology, and discusses the crucial patent and patent holder, respectively, by the statistic of highly cited patent and main path analysis.

The purpose of this study is to use a patent analysis of the current market status, summarize the critical technology development path of patent technology and the crucial manufacturers, provide relevant patent and information to companies, and help to make a business strategy of intellectual property management.

英文參考文獻

1. Albisser, A. M., Leibel, B., Ewart, T., Davidovac, Z., Botz, C., Zingg, W., . . . Gander, R. (1974). Clinical control of diabetes by the artificial pancreas. Diabetes, 23(5), 397-404.
2. Ashton, W. B., & Sen, R. K. (1988). Using patent information in technology business planning—I. Research-Technology Management, 31(6), 42-46.
3. Association, A. D. (2009). Diagnosis and classification of diabetes mellitus. Diabetes care, 32(Supplement 1), S62-S67.
4. Association, A. D. (2020). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes care, 43(Supplement 1), S14-S31. doi: 10.2337/dc20-S002
5. Cappon, G., Acciaroli, G., Vettoretti, M., Facchinetti, A., & Sparacino, G. (2017). Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment. Electronics, 6(3), 65.
6. Cass, A. E., Davis, G., Francis, G. D., Hill, H. A. O., Aston, W. J., Higgins, I. J., . . . Turner, A. P. (1984). Ferrocene-mediated enzyme electrode for amperometric determination of glucose. Analytical chemistry, 56(4), 667-671.
7. Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, 138, 271-281. doi: 10.1016/j.diabres.2018.02.023
8. Clark Jr, L. C., & Lyons, C. (1962). Electrode systems for continuous monitoring in cardiovascular surgery. Annals of the New York Academy of sciences, 102(1), 29-45.
9. Clarke, S., & Foster, J. (2012). A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. British journal of biomedical science, 69(2), 83-93.
10. Deng, Z., Lev, B., & Narin, F. (1999). Science and technology as predictors of stock performance. Financial Analysts Journal, 55(3), 20-32.
11. Dosi, G. (1982). Technological paradigms and technological trajectories: a suggested interpretation of the determinants and directions of technical change. Research policy, 11(3), 147-162.
12. Ernst, H. (1998). Patent portfolios for strategic R&D planning. Journal of engineering and technology management, 15(4), 279-308.
13. Ferguson, S., & Hughes, I. (1980). Are reflectance meters necessary for home blood glucose monitoring? British medical journal, 281(6253), 1494.
14. Gifford, R. (2013). Continuous glucose monitoring: 40 Years, what we've learned and what's next. ChemPhysChem, 14(10), 2032-2044.
15. Goldstein, D. E., Little, R. R., Lorenz, R. A., Malone, J. I., Nathan, D., Peterson, C. M., & Sacks, D. B. (2004). Tests of Glycemia in Diabetes. Diabetes care, 27(7), 1761-1773. doi: 10.2337/diacare.27.7.1761
16. Hall, B. H., Jaffe, A. B., & Trajtenberg, M. (2000). Market value and patent citations: A first look: national bureau of economic research Cambridge, Mass., USA.
17. Heinemann, L., & DeVries, J. H. (2016). Reimbursement for continuous glucose monitoring. Diabetes technology & therapeutics, 18(S2), S2-48-S42-52.
18. Juska, V. B., & Pemble, M. E. (2020). A critical review of electrochemical glucose sensing: evolution of biosensor platforms based on advanced nanosystems. Sensors, 20(21), 6013.
19. Mogee, M. E. (1991). Using patent data for technology analysis and planning. Research-Technology Management, 34(4), 43-49.
20. Papaspyros, N. S. (1964). The history of diabetes mellitus (Vol. 1964): G. Thieme.
21. Shichiri, M., Yamasaki, Y., Kawamori, R., Hakui, N., & Abe, H. (1982). Wearable artificial endocrine pancreas with needle-type glucose sensor. The Lancet, 320(8308), 1129-1131.
 
中文參考文獻

1. 江冠世（2017）。非侵入式血糖量測技術專利分析。未出版之碩士論文，國立臺灣科技大學專利研究所，台北市。
2. 呂聖華（2016）。血糖量測技術專利分析之研究。未出版之碩士論文，國立臺灣科技大學專利研究所，台北市。
3. 阮明淑, & 梁峻齊（2009）。專利指標發展研究。圖書館學與資訊科學， 35（2）。
4. 陳達仁（2017）。專利檢索與專利分析（第四版）（第1冊）。 台北市：經濟部智慧財產局。
5. 黃俊達, & 李淳權（2020）。測量血糖的新趨勢: 即時性連續血糖監測 (Real-time CGM)。內科學誌， 31（1），頁 30-39。
6. 黃彥臻, 游佩芬, & 李逸揚（2010）。糖尿病監測與照護之新興技術展望及商機剖析（1）（第1冊）。 台北市：經濟部。
7. 黃莉棋, 陳瑜忻, 李治中, & 林慶齡（2016）。由最新的國際標準規格看血糖機精準的必要性與影響檢測準確的因素。內科學誌， 27（5），頁 239-247。
8. 新井喜美雄（1993）。特許情報解析による技術の動向・分布調査 (特集: 特許戦争に打ち勝つための情報戦略)。情報の科学と技術， 43（8），頁 728-739。
9. 劉國讚, & 柯正怡（2013）。隱藏在專利件數背後的專利強度指標。專利師。
10. 賴奎魁, 林美蘭, 張淑敏, & 張善斌. (2006)。專利分析相關文獻之分類研究: 採用書目計量學方法。科技管理學刊, 11(1), 137-168.。
11. 賴麗珍（2009）。生物感測器。科儀新知（170），頁 39-46。
12. 顏嘉德, & 吳靖宙（2017）。電化學式連續監控型葡萄糖生物感測器之發展。科儀新知（213），頁 57-67。